Altered Serum MicroRNA Profile May Serve as an Auxiliary Tool for Discriminating Aggressive Thyroid Carcinoma from Nonaggressive Thyroid Cancer and Benign Thyroid Nodules

Figure 4

The ROC curves of 2 serum miRNAs in the MTC patients compared with healthy controls or the benign nodule subjects. ROC curves indicate the ability of serum analysis of the 2 individual miRNAs, miR-222-3p and miR-17-5p, in individuals or combined, to differentiate cases of MTC from healthy controls (a–c) and the benign nodule subjects (d–f).

(a)

(b)

(c)

(d)

(e)

(f)